Low-dose radiation offers new option for osteoarthritis treatment in East-Central Illinois


Low-dose radiation therapy has been used for decades in Europe to treat joint pain and inflammatory conditions. OSF HealthCare Bobette Steely Hegeler Cancer Center is expanding its services to include low-dose radiation therapy for osteoarthritis.


DANVILLE - Long known for cancer care, OSF HealthCare Bobette Steely Hegeler Cancer Center is expanding its services to include low-dose radiotherapy, or LDRT, for patients living with osteoarthritis and other inflammatory or degenerative conditions affecting joints, tendons and soft tissues.

The therapy uses radiation at doses far lower than those used in cancer treatment to reduce inflammation and pain. While the approach may be unfamiliar to many U.S. patients, LDRT has a long clinical history and is widely used in parts of Europe to treat noncancerous musculoskeletal conditions.


Radiation Oncologist Dr. Edie Krueger at OSF
Photo provided


Edie Krueger, MD
Radiation Oncologist
Hegeler Cancer Center




“People who have tried other treatments but are not ready for surgery are great candidates for LDRT,” said Dr. Edie Krueger, a radiation oncologist at Hegeler Cancer Center. “This is a safe, effective and noninvasive treatment that can significantly reduce pain and stiffness, possibly avoiding the need for surgery.”

A century-old idea gaining renewed attention

Low-dose radiation has been used for more than 100 years to treat painful inflammatory conditions, predating many modern medications and surgical techniques. For decades, it has been applied to disorders such as plantar fasciitis, tennis elbow and other degenerative joint diseases. In recent years, interest has returned as researchers reexamined its anti-inflammatory effects and potential role in managing osteoarthritis, the most common form of arthritis.

Osteoarthritis affects an estimated 32.5 million adults in the United States. It occurs when cartilage that cushions joints gradually wears down, leading to pain, stiffness and reduced mobility. Knees and hips are most commonly affected, often limiting daily activities and quality of life.

“People with painful knee osteoarthritis often face a difficult choice between the risks of side effects from pain medications and the risks of joint replacement surgery,” said Dr. Byoung Hyuck Kim, a radiation oncologist at Seoul National University College of Medicine and principal investigator on a recent clinical trial. “There’s a clinical need for moderate interventions between weak pain medications and aggressive surgery, and we think radiation may be a suitable option for those patients, especially when drugs and injections are poorly tolerated.”

How LDRT works

Unlike cancer radiotherapy, which targets and destroys malignant cells, LDRT is believed to work by modulating the body’s inflammatory response. Researchers say low doses of radiation can reduce the production of pro-inflammatory cytokines and influence immune cells involved in chronic joint inflammation.

The precise biological mechanism is still being studied, but current evidence suggests LDRT dampens inflammation without damaging healthy cartilage. Reviews of experimental and clinical studies have found either neutral or beneficial effects on joint tissue when low doses are used.

“There is a misconception that medicinal, or therapeutic, radiation is always delivered in high doses,” Kim said. “But for osteoarthritis, the doses are only a small fraction of what we use for cancer, and the treatment targets joints that are positioned away from vital organs, which lowers the likelihood of side effects.”


Photo courtesy OSF Healthcare

The linear accelerator at OSF is a medical device that uses microwave technology to accelerate electrons to near light speed used for cancer treatment. The TrueBeam® model pictured was installed in 2022.

Who may benefit

Doctors say LDRT is best suited for patients with chronic joint pain who have not found sufficient relief from medications, physical therapy or injections, but who are not ready for — or are not candidates for — surgery.

“This therapy does not change the joint structure itself,” said Dr. Matthew Harkenrider, a radiation oncologist at Loyola Medicine. “Instead, it helps relieve the inflammation that contributes to pain.”

Research suggests about 70 percent of osteoarthritis patients experience some level of pain reduction or improved joint function after LDRT, according to Loyola Medicine. Many patients report improvements in mobility, allowing them to return to activities such as walking, gardening or golfing with less discomfort.

Side effects and safety

LDRT is generally considered well tolerated. Most studies report only mild, temporary side effects, such as slight skin irritation or short-term fatigue. Serious adverse effects have not been commonly observed in clinical trials.

Because radiation exposure is involved, the risk of secondary cancers is often raised as a concern. However, researchers note that the total doses used in LDRT — typically between 3 and 6 gray — are well below levels associated with a significant increase in cancer risk. In addition, treatment is localized to joints, which are not considered highly susceptible to malignancy, and most patients treated for osteoarthritis are older adults, reducing long-term risk.

Use beyond the United States

Low-dose radiation therapy for joint pain is widely accepted in countries such as Germany and Spain, where it is routinely offered as part of standard care. Awareness remains lower in the United States, partly due to limited large-scale randomized trials in the past and lingering assumptions about radiation risks.

Recent studies and growing clinical experience, however, have renewed interest among U.S. providers seeking noninvasive options for patients with chronic joint pain.

“For many osteoarthritis patients, low-dose radiation therapy offers a safe, effective and well-tolerated treatment that improves mobility and enhances overall quality of life,” Harkenrider said.

As OSF HealthCare Bobette Steely Hegeler Cancer Center expands its offerings, clinicians hope LDRT will fill a treatment gap for patients caught between temporary pain relief and major surgery, providing another option to manage chronic joint pain closer to home.

Treatment at Hegeler Cancer Center

At OSF HealthCare Bobette Steely Hegeler Cancer Center, LDRT treatments are delivered using the TrueBeam® linear accelerator, installed in 2022. The system allows clinicians to precisely target affected joints while minimizing exposure to surrounding tissue.

Each treatment session lasts about 15 minutes. Most patients undergo six treatments over a two-week period, followed by a check-in three months later. Depending on symptom response, a physician may recommend an additional round.

Patients must have a referral from a health care provider. Those interested are encouraged to speak with their care team or call the cancer center at (217) 431-4290. The center is located at 806 N. Logan Ave. on the campus of OSF Sacred Heart Medical Center.




TAGS: low-dose radiation therapy osteoarthritis Illinois, OSF HealthCare joint pain treatment, noninvasive osteoarthritis therapy Danville, Hegeler Cancer Center LDRT, radiation therapy for inflammatory joint conditions


More Sentinel Stories